Promoting Informed Choice for Breast Cancer Screening

University of Colorado Denver (CU Denver)

Status: Active, not recruiting

Conditions: Breast Cancer

Treatments: Behavioral: Decision aid

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05376241

R01CA254926 (Other Grant/Funding Number)

20-1866.cc

Details and patient eligibility

About

Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.

Full description

In this study, the goal is to identify the prevalence and predictors of reactance, self-exemption, disbelief, and source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust. Research has not yet systematically identified the proportion of women who respond negatively (vs. positively) to evidence about the benefits and harms of mammography screening, or attempted to explain these responses by examining theory-driven predictors. The Investigator will develop and conduct a probability-based nationally representative survey in which mammography evidence is communicated using current best practices in risk communication. The Investigators will identify theory-driven predictors of negative and positive responses to that evidence, and identify consequences of these responses for screening decision-making and trust.

Enrollment: 498 patients

Sex: Female

Ages: 39 to 49 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female
• Between 39-49 years of age
• No history of breast cancer
• No known BRCA 1/2 mutation

Exclusion criteria

• Non-English or Spanish Speaking
• Persons unable to provide informed consent (e.g. sever dementia or cognitive disability or illiterate
• History of breast cancer
• Known BRCA 1/2 mutation

Trial design

498 participants in 1 patient group

Women age 39-49 in the United States

Description:

The group is women age 39-49 in the United States who receive a decision aid intervention. The intervention is a breast cancer screening decision aid with information about screening guidelines, breast cancer mortality reduction, false positives, overdiagnosis, and a personal breast cancer risk estimate.

Treatment:

Behavioral: Decision aid